The funds will be deployed to strengthen the Continulus management team, as well as enhancing the company’s technological capacity to permit its continuing expansion and collaboration with some of the world’s most highly respected medical organisations.

Continulus already has global partnerships with a range of medical bodies including the Australian College of Critical Care Nurses. In addition, the company has entered a marketing partnership with EB Medicine, an education provider for doctors with 65,000 members in emergency medicine in the USA.

Dr Eoghan Colgan, founder and chief executive, said: “With existing users in 89 countries and growing, our long-term aim is to become one of the leading global healthcare education providers and to form a worldwide network that can be used to address global healthcare challenges. This investment represents a major step forward in fulfilling our ambitions.

“Both the COVID-19 pandemic and climate change are important factors in our growth since Continulus gives all our users online access to conferences, lectures and events at which, previously, professionals would have had to be physically present.”

Dr Colgan, who continues to work in the Accident & Emergency Department at Glasgow’s Royal Infirmary, added: “Our partnerships are an endorsement of the work we are doing in acute and critical care specialities where we will be providing a package of lectures, multi-camera tutorials and podcasts by the world’s most authoritative experts.”

Graham McDonald, former head of Global Private Equity at Aberdeen Standard Investments who led the investment consortium, added: “It is exciting to be shortening the knowledge translation gap from high-impact evidence-based research to frontline practice by bringing together the leading researchers and subject experts onto one platform, with Continulus facilitating this global network.”